Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter, open label, randomized, balanced, two treatment, two period, two sequence, two way crossover, multiple dose, comparative oral bioavailability study of Imatinib mesylate tablets 400mg of Onco Therapies Limited (a subsidiary of Strides Arcolab Ltd.), India with Gleevec (Imatinib Mesylate) Tablets 400mg of Novartis Pharmaceuticals Corporation, East Hanover, New Jersey in adult human patients with Chronic Myeloid Leukemia and/or Gastrointestinal Stromal Tumor under fed steady-state condition

Next Previous
X
Search
Trial Profile

A multicenter, open label, randomized, balanced, two treatment, two period, two sequence, two way crossover, multiple dose, comparative oral bioavailability study of Imatinib mesylate tablets 400mg of Onco Therapies Limited (a subsidiary of Strides Arcolab Ltd.), India with Gleevec (Imatinib Mesylate) Tablets 400mg of Novartis Pharmaceuticals Corporation, East Hanover, New Jersey in adult human patients with Chronic Myeloid Leukemia and/or Gastrointestinal Stromal Tumor under fed steady-state condition

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imatinib (Primary)
  • Indications Chronic myeloid leukaemia; Gastrointestinal stromal tumours
  • Focus Pharmacokinetics

    • Most Recent Events

    • 06 May 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 12 Mar 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top